What types of ocular inflammatory disease may be studied in clinical trials?

Clinical trials may study many different forms of ocular inflammatory disease, including uveitis and inflammation associated with systemic autoimmune or inflammatory conditions. Studies may focus on a specific type or location of inflammation, such as anterior, intermediate, posterior, or panuveitis, or may be designed for people with a particular underlying condition. Because each study has its own eligibility requirements, having a diagnosis of OID does not necessarily mean you will qualify for a particular trial.

How do I know if I might qualify for a clinical trial?

Every clinical trial has specific inclusion and exclusion criteria. These may include your diagnosis and type of uveitis, age, how active your inflammation is, previous treatments, current medications, other medical conditions, and whether you have had certain procedures or complications. For example, a study may require active inflammation, while another may require inflammation to be controlled. Some studies may require participants to have tried or failed certain medications before enrolling. The study team—not OIUF—will determine whether you meet the eligibility requirements.

Can I participate if my uveitis is currently controlled?

Possibly. Some studies specifically look for patients with active disease, while others may study people whose inflammation is controlled or who are receiving maintenance treatment. If you are interested in research, it may still be worthwhile to look at available studies even if you are currently doing well.

Can I participate if I am already taking medication for my OID?

It depends on the study. Some clinical trials allow participants to continue certain medications, while others may require participants to stop, reduce, or change particular treatments. Do not stop or change your medications in order to qualify for a clinical trial. Discuss any potential study with your treating physician and the research team.

Will participating in a clinical trial replace my regular uveitis care?

Not necessarily. Some trials involve additional visits or may take place at a different medical center from where you normally receive care. Before enrolling, ask the research team how participation will affect your existing care and how communication between the study team and your regular ophthalmologist or other physicians will be handled.

Research Collaborations

Progress in ocular inflammatory disease depends on collaboration. By bringing together physicians, researchers, institutions, and the patient community, we can expand our understanding of OID and accelerate the development of better treatments and approaches to care.

OIUF welcomes opportunities to collaborate with members of the broader medical and research community whose work aligns with our mission to advance knowledge and improve the lives of people living with ocular inflammatory disease.

We are interested in connecting with physicians and researchers working in areas such as:

Ocular inflammatory disease and uveitis
Autoimmune and systemic inflammatory diseases affecting the eye
Clinical and translational research
Patient-reported outcomes and quality of life
Disease education and awareness
Clinical trials and research participation
Research that addresses unmet needs within the OID community

Collaboration opportunities may include sharing research opportunities with the OID community, connecting researchers with relevant resources or expertise, supporting educational initiatives, and exploring opportunities for joint research and academic projects.

Have a Research Idea or Opportunity?

If you are conducting research relevant to ocular inflammatory disease or have an idea for a potential collaboration, we would be interested in hearing from you.
Please contact us to tell us about your project, research interests, or potential opportunity. While we cannot guarantee that OIUF will be able to participate in or promote every project, we welcome conversations that may help advance OID research and benefit the broader community.

Collaborate in Research

Advancing Ocular Inflammatory Disease Research Together

Our Interest

We are interested in connecting with physicians and researchers working in areas such as:

Have a Research Idea or Opportunity?

Research Highlights

Bio of the Rearcher

Bio 2 of Researcher